Mouse models of heart failure: cell signaling and cell survival.

Heart failure is one of the paramount global causes of morbidity and mortality. Despite this pandemic need, the available clinical counter-measures have not altered substantially in recent decades, most notably in the context of pharmacological interventions. Cell death plays a causal role in heart failure, and its inhibition poses a promising approach that has not been thoroughly explored. In previous approaches to target discovery, clinical failures have reflected a deficiency in mechanistic understanding, and in some instances, failure to systematically translate laboratory findings toward the clinic. Here, we review diverse mouse models of heart failure, with an emphasis on those that identify potential targets for pharmacological inhibition of cell death, and on how their translation into effective therapies might be improved in the future.

[1]  Wei Huang,et al.  &agr;B-Crystallin Modulates Protein Aggregation of Abnormal Desmin , 2003, Circulation research.

[2]  G. King,et al.  Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart. , 1999, Circulation.

[3]  E. Alnemri,et al.  Role of Omi/HtrA2 in Apoptotic Cell Death After Myocardial Ischemia and Reperfusion , 2005, Circulation.

[4]  P. Ping,et al.  Enhanced PKC beta II translocation and PKC beta II-RACK1 interactions in PKC epsilon-induced heart failure: a role for RACK1. , 2001, American journal of physiology. Heart and circulatory physiology.

[5]  Dongyin Zhang,et al.  Cardioprotective effects of exenatide against oxidative stress-induced injury. , 2013, International journal of molecular medicine.

[6]  G. Bonne,et al.  Striated muscle laminopathies. , 2014, Seminars in cell & developmental biology.

[7]  Jeffrey Robbins,et al.  A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy , 1998, Cell.

[8]  Tong Zhang,et al.  Transgenic CaMKII&dgr;C Overexpression Uniquely Alters Cardiac Myocyte Ca2+ Handling: Reduced SR Ca2+ Load and Activated SR Ca2+ Release , 2003, Circulation research.

[9]  Frederick J. Schoen,et al.  A Mouse Model of Familial Hypertrophic Cardiomyopathy , 1996, Science.

[10]  P. Ping,et al.  PKCε activation induces dichotomous cardiac phenotypes and modulates PKCε-RACK interactions and RACK expression , 2001 .

[11]  G. Stone,et al.  Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial. , 2013, JACC. Cardiovascular interventions.

[12]  Eric P. Hoffman,et al.  Dystrophin: The protein product of the duchenne muscular dystrophy locus , 1987, Cell.

[13]  Thomas M. Keane,et al.  Mouse genomic variation and its effect on phenotypes and gene regulation , 2011, Nature.

[14]  M. Eren,et al.  Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo. , 2006, American journal of physiology. Heart and circulatory physiology.

[15]  H. Moser,et al.  Duchenne muscular dystrophy: Pathogenetic aspects and genetic prevention , 2004, Human Genetics.

[16]  P. Ellinor,et al.  RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing , 2012, Nature Medicine.

[17]  D. Kelsell,et al.  Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. , 2000, Human molecular genetics.

[18]  D. Kass,et al.  Combined TRPC3 and TRPC6 blockade by selective small-molecule or genetic deletion inhibits pathological cardiac hypertrophy , 2014, Proceedings of the National Academy of Sciences.

[19]  Euan A. Ashley,et al.  Patient-Specific Induced Pluripotent Stem Cells as a Model for Familial Dilated Cardiomyopathy , 2012, Science Translational Medicine.

[20]  Tong Zhang,et al.  Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice. , 2009, The Journal of clinical investigation.

[21]  G. Dorn,et al.  Protein Kinase C (cid:1) Negatively Regulates Systolic and Diastolic Function in Pathological Hypertrophy , 2022 .

[22]  Lei Shi,et al.  Structural and dynamic basis of phospholamban and sarcolipin inhibition of Ca(2+)-ATPase. , 2008, Biochemistry.

[23]  C. Scheidereit,et al.  The Prevalence of TNFα-Induced Necrosis over Apoptosis Is Determined by TAK1-RIP1 Interplay , 2011, PloS one.

[24]  Young-Jae Nam,et al.  The Mitochondrial Death Pathway and Cardiac Myocyte Apoptosis , 2004, Circulation research.

[25]  R. Schwinger,et al.  TNF and congestive heart failure: therapeutic possibilities , 2004, Expert opinion on therapeutic targets.

[26]  P. Serruys,et al.  Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. , 1986, Journal of the American College of Cardiology.

[27]  R. Lang,et al.  Dilated cardiomyopathy in transgenic mice expressing a dominant-negative CREB transcription factor in the heart. , 1998, The Journal of clinical investigation.

[28]  M. Prevost,et al.  A missense mutation in the αB-crystallin chaperone gene causes a desmin-related myopathy , 1998, Nature Genetics.

[29]  J. Seidman,et al.  5'RNA-Seq identifies Fhl1 as a genetic modifier in cardiomyopathy. , 2014, The Journal of clinical investigation.

[30]  R. Kitsis,et al.  Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vivo. , 2003, American journal of physiology. Heart and circulatory physiology.

[31]  G. Dorn,et al.  Transgenic Gαq overexpression induces cardiac contractile failure in mice , 1997 .

[32]  I. Komuro,et al.  p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload , 2007, Nature.

[33]  G. Dorn,et al.  Protein kinase cascades in the regulation of cardiac hypertrophy. , 2005, The Journal of clinical investigation.

[34]  Yibin Wang Mitogen-activated protein kinases in heart development and diseases. , 2007, Circulation.

[35]  S. Vatner,et al.  Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy. , 2003, The Journal of clinical investigation.

[36]  Rick B. Vega,et al.  Regulation of Cardiac Stress Signaling by Protein Kinase D1 , 2006, Molecular and Cellular Biology.

[37]  Y. Ho,et al.  Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice. , 2001, American journal of physiology. Heart and circulatory physiology.

[38]  C. Hanis,et al.  Genome-Wide Linkage and Admixture Mapping of Type 2 Diabetes in African American Families From the American Diabetes Association GENNID (Genetics of NIDDM) Study Cohort , 2009, Diabetes.

[39]  E. Olson,et al.  Calcium/Calmodulin-Dependent Protein Kinase II Contributes to Cardiac Arrhythmogenesis in Heart Failure , 2009, Circulation. Heart failure.

[40]  M. Wheeler,et al.  Cardiomyopathy is independent of skeletal muscle disease in muscular dystrophy , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  C. di Loreto,et al.  Myocyte proliferation in end-stage cardiac failure in humans. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[42]  S. Korsmeyer,et al.  Inhibition of both the extrinsic and intrinsic death pathways through nonhomotypic death-fold interactions. , 2004, Molecular cell.

[43]  D. Mann,et al.  Left Ventricular Remodeling in Transgenic Mice With Cardiac Restricted Overexpression of Tumor Necrosis Factor , 2001, Circulation.

[44]  D. Wagner,et al.  The role of tumor necrosis factor in the pathophysiology of heart failure. , 2000, Journal of the American College of Cardiology.

[45]  W. Robb MacLellan,et al.  Systems-based approaches to cardiovascular disease , 2012, Nature Reviews Cardiology.

[46]  J. Saffitz,et al.  Desmin-related cardiomyopathy in transgenic mice: a cardiac amyloidosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[47]  R. Lefkowitz,et al.  Cardiac beta ARK1 inhibition prolongs survival and augments beta blocker therapy in a mouse model of severe heart failure. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[48]  K. Davies,et al.  Diaphragm rescue alone prevents heart dysfunction in dystrophic mice. , 2011, Human molecular genetics.

[49]  D. Yellon,et al.  Cyclosporin A and cardioprotection: from investigative tool to therapeutic agent , 2012, British journal of pharmacology.

[50]  中川 崇 Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. , 2005 .

[51]  A. Chawla,et al.  Identification of Map4k4 as a Novel Suppressor of Skeletal Muscle Differentiation , 2012, Molecular and Cellular Biology.

[52]  G Baumgarten,et al.  Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[53]  S. Wright Pathophysiology of congestive heart failure , 1990, The Journal of cardiovascular nursing.

[54]  G. Dorn,et al.  ε Protein Kinase C in Pathological Myocardial Hypertrophy , 2000, The Journal of Biological Chemistry.

[55]  M. Noseda,et al.  Cardiopoietic factors: extracellular signals for cardiac lineage commitment. , 2011, Circulation research.

[56]  O. H. Bing Hypothesis: apoptosis may be a mechanism for the transition to heart failure with chronic pressure overload. , 1994, Journal of molecular and cellular cardiology.

[57]  J. Chachques,et al.  Animal models of heart failure: what is new? , 2005, The Annals of thoracic surgery.

[58]  B. Moss,et al.  A Role for Tumor Necrosis Factor Receptor-2 and Receptor-interacting Protein in Programmed Necrosis and Antiviral Responses* , 2003, Journal of Biological Chemistry.

[59]  K. Vranizan,et al.  Conditional expression of a Gi-coupled receptor causes ventricular conduction delay and a lethal cardiomyopathy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[60]  D. Srivastava,et al.  Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signaling. , 2009, Developmental cell.

[61]  Joseph A. Hill,et al.  Impaired Autophagosome Clearance Contributes to Cardiomyocyte Death in Ischemia/Reperfusion Injury , 2012, Circulation.

[62]  M Rayner,et al.  Cost of cardiovascular diseases in the United Kingdom , 2006, Heart.

[63]  Xuejun Jiang,et al.  Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. , 2002, Molecular cell.

[64]  J. Ross,et al.  Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[65]  P. Robbins,et al.  Soluble tumor necrosis factor receptor abrogates myocardial inflammation but not hypertrophy in cytokine-induced cardiomyopathy. , 2000, Circulation.

[66]  M. Crackower,et al.  Temporally Regulated and Tissue-Specific Gene Manipulations in the Adult and Embryonic Heart Using a Tamoxifen-Inducible Cre Protein , 2001, Circulation research.

[67]  Jeffrey Robbins,et al.  Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death , 2005, Nature.

[68]  W. Liu,et al.  Journal of Cardiovascular Magnetic Resonance Open Access Early Manifestation of Alteration in Cardiac Function in Dystrophin Deficient Mdx Mouse Using 3d Cmr Tagging , 2009 .

[69]  J. Inoue,et al.  Recruitment of Tumor Necrosis Factor Receptor-associated Factor Family Proteins to Apoptosis Signal-regulating Kinase 1 Signalosome Is Essential for Oxidative Stress-induced Cell Death* , 2005, Journal of Biological Chemistry.

[70]  V. Mootha,et al.  tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. , 2000, Genes & development.

[71]  M. Czech,et al.  Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes , 2008, Nature Reviews Molecular Cell Biology.

[72]  R. Virmani,et al.  Apoptosis in myocytes in end-stage heart failure. , 1996, The New England journal of medicine.

[73]  T. Doetschman,et al.  Cardiac-specific inducible and conditional gene targeting in mice. , 2012, Circulation research.

[74]  G. Gibson,et al.  Genetic Variation for Cardiac Dysfunction in Drosophila , 2007, PloS one.

[75]  Joseph Avruch,et al.  Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. , 2012, Physiological reviews.

[76]  I. Benjamin,et al.  Autophagy is an adaptive response in desmin-related cardiomyopathy , 2007, Proceedings of the National Academy of Sciences.

[77]  K. Campbell,et al.  Disruption of the Sarcoglycan–Sarcospan Complex in Vascular Smooth Muscle A Novel Mechanism for Cardiomyopathy and Muscular Dystrophy , 1999, Cell.

[78]  Yibin Wang,et al.  The p38 mitogen-activated protein kinase pathway--a potential target for intervention in infarction, hypertrophy, and heart failure. , 2011, Journal of molecular and cellular cardiology.

[79]  M. Martone,et al.  Chronic Phospholamban–Sarcoplasmic Reticulum Calcium ATPase Interaction Is the Critical Calcium Cycling Defect in Dilated Cardiomyopathy , 1999, Cell.

[80]  D. Mochly‐Rosen,et al.  Reperfusion-Induced Translocation of &dgr;PKC to Cardiac Mitochondria Prevents Pyruvate Dehydrogenase Reactivation , 2005, Circulation research.

[81]  K. Hizawa,et al.  Life spans of Duchenne muscular dystrophy patients in the hospital care program in Japan , 1987, Journal of the Neurological Sciences.

[82]  A. Harken,et al.  Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1β , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[83]  Chun Guo,et al.  Absence of alpha 7 integrin in dystrophin-deficient mice causes a myopathy similar to Duchenne muscular dystrophy. , 2006, Human molecular genetics.

[84]  Chun-Keung Yu,et al.  Prostaglandin E2 promotes post-infarction cardiomyocyte replenishment by endogenous stem cells , 2014, EMBO molecular medicine.

[85]  G. Dorn,et al.  Inhibition of Cardiac Myocyte Apoptosis Improves Cardiac Function and Abolishes Mortality in the Peripartum Cardiomyopathy of G&agr;q Transgenic Mice , 2003, Circulation.

[86]  I. Komuro,et al.  ATF6 is important under both pathological and physiological states in the heart. , 2010, Journal of molecular and cellular cardiology.

[87]  John W. Adams,et al.  Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[88]  Tomoki Nakamura,et al.  Genetic approaches for changing the heart and dissecting complex syndromes. , 2008, Journal of molecular and cellular cardiology.

[89]  T. Kita,et al.  Activation of TGF-beta1-TAK1-p38 MAPK pathway in spared cardiomyocytes is involved in left ventricular remodeling after myocardial infarction in rats. , 2006, American journal of physiology. Heart and circulatory physiology.

[90]  L. A. Anwer,et al.  Cardiac SERCA2A/B: therapeutic targets for heart failure. , 2014, European journal of pharmacology.

[91]  Nektarios Tavernarakis,et al.  Functional and physical interaction between Bcl‐XL and a BH3‐like domain in Beclin‐1 , 2007, The EMBO journal.

[92]  R. Hajjar,et al.  CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury. , 2007, Cardiovascular research.

[93]  Karen Ocorr,et al.  A Global In Vivo Drosophila RNAi Screen Identifies NOT3 as a Conserved Regulator of Heart Function , 2010, Cell.

[94]  B. Blaxall,et al.  Phospholipase Cε Hydrolyzes Perinuclear Phosphatidylinositol 4-Phosphate to Regulate Cardiac Hypertrophy , 2013, Cell.

[95]  P. Anversa,et al.  End-stage cardiac failure in humans is coupled with the induction of proliferating cell nuclear antigen and nuclear mitotic division in ventricular myocytes. , 1994, Circulation research.

[96]  Jing Chen,et al.  Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK–ERK independent mechanism , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[97]  J. Molkentin,et al.  Temporal activation of c‐Jun N‐terminal kinase in adult transgenic heart via cre‐loxP‐mediated DNA recombination , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[98]  Mutations in the human δ-sarcoglycan gene in familial and sporadic dilated cardiomyopathy , 2000 .

[99]  J. Schaper,et al.  Myocytes Die by Multiple Mechanisms in Failing Human Hearts , 2003, Circulation research.

[100]  K. Zsebo,et al.  Long-Term Effects of AAV1/SERCA2a Gene Transfer in Patients With Severe Heart Failure: Analysis of Recurrent Cardiovascular Events and Mortality , 2014, Circulation research.

[101]  G. Dorn,et al.  Intracellular transport mechanisms of signal transducers. , 2002, Annual review of physiology.

[102]  C. Rubin,et al.  Protein kinase D: coupling extracellular stimuli to the regulation of cell physiology , 2011, EMBO reports.

[103]  D. Bernstein,et al.  Deletion of the β2-adrenergic receptor prevents the development of cardiomyopathy in mice. , 2013, Journal of molecular and cellular cardiology.

[104]  K. Toth,et al.  Puma Deletion Delays Cardiac Dysfunction in Murine Heart Failure Models Through Attenuation of Apoptosis , 2011, Circulation.

[105]  H. Tsui,et al.  Pak1 as a Novel Therapeutic Target for Antihypertrophic Treatment in the Heart , 2011, Circulation.

[106]  V. Kryštof,et al.  Pharmacological targeting of CDK9 in cardiac hypertrophy , 2009, Medicinal research reviews.

[107]  Minoru Hongo,et al.  MLP-Deficient Mice Exhibit a Disruption of Cardiac Cytoarchitectural Organization, Dilated Cardiomyopathy, and Heart Failure , 1997, Cell.

[108]  R. Kayed,et al.  Exercise reverses preamyloid oligomer and prolongs survival in αB-crystallin-based desmin-related cardiomyopathy , 2007, Proceedings of the National Academy of Sciences.

[109]  G. Danieli,et al.  Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. , 2002, American journal of human genetics.

[110]  R. Kayed,et al.  Reversal of amyloid-induced heart disease in desmin-related cardiomyopathy. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[111]  J. Sanes,et al.  Skeletal and Cardiac Myopathies in Mice Lacking Utrophin and Dystrophin: A Model for Duchenne Muscular Dystrophy , 1997, Cell.

[112]  Tetsuya Watanabe,et al.  Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death , 2005, Nature.

[113]  Sangita Choudhury,et al.  Moderate and high amounts of tamoxifen in αMHC-MerCreMer mice induce a DNA damage response, leading to heart failure and death , 2013, Disease Models & Mechanisms.

[114]  Dimitrios Georgakopoulos,et al.  The pathogenesis of familial hypertrophic cardiomyopathy: Early and evolving effects from an α-cardiac myosin heavy chain missense mutation , 1999, Nature Medicine.

[115]  Herman I. May,et al.  Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis , 2012, Nature.

[116]  M. Entman,et al.  Abstract 1949: The Protein Kinase MAP4K4 Is Activated in Failing Human Hearts and Mediates Cardiomyocyte Apoptosis in Experimental Models, in vitro and in vivo , 2007 .

[117]  Yibin Wang,et al.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. , 2010, Physiological reviews.

[118]  G. Fishman,et al.  Expression of protein kinase C beta in the heart causes hypertrophy in adult mice and sudden death in neonates. , 1997, The Journal of clinical investigation.

[119]  G. Vorobiof,et al.  Small Molecule Disruption of G&bgr;&ggr; Signaling Inhibits the Progression of Heart Failure , 2010, Circulation research.

[120]  D. Mann,et al.  Targeted Overexpression of Transmembrane Tumor Necrosis Factor Provokes a Concentric Cardiac Hypertrophic Phenotype , 2003, Circulation.

[121]  F. Clubb,et al.  Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. , 1998, Circulation.

[122]  S. Vatner,et al.  Cardiomyopathy induced by cardiac Gs alpha overexpression. , 1997, The American journal of physiology.

[123]  Chetana Sachidanandan,et al.  In vivo natriuretic peptide reporter assay identifies chemical modifiers of hypertrophic cardiomyopathy signalling. , 2012, Cardiovascular research.

[124]  M. Periasamy,et al.  Sarcolipin and phospholamban as regulators of cardiac sarcoplasmic reticulum Ca2+ ATPase. , 2007, Journal of molecular and cellular cardiology.

[125]  J. Metzger,et al.  Direct, Differential Effects of Tamoxifen, 4-Hydroxytamoxifen, and Raloxifene on Cardiac Myocyte Contractility and Calcium Handling , 2013, PloS one.

[126]  G. Dorn,et al.  Additive protection of the ischemic heart ex vivo by combined treatment with delta-protein kinase C inhibitor and epsilon-protein kinase C activator. , 2003, Circulation.

[127]  R. Passier,et al.  CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. , 2000, The Journal of clinical investigation.

[128]  A. Sanbe Molecular mechanisms of α-crystallinopathy and its therapeutic strategy. , 2011, Biological & pharmaceutical bulletin.

[129]  J. Seidman,et al.  Altered cardiac excitation-contraction coupling in mutant mice with familial hypertrophic cardiomyopathy. , 1999, The Journal of clinical investigation.

[130]  T. Asano,et al.  Distinct Roles of Autophagy in the Heart During Ischemia and Reperfusion: Roles of AMP-Activated Protein Kinase and Beclin 1 in Mediating Autophagy , 2007, Circulation research.

[131]  N. Maulik,et al.  Bax ablation protects against myocardial ischemia-reperfusion injury in transgenic mice. , 2003, American journal of physiology. Heart and circulatory physiology.

[132]  Stefan J Riedl,et al.  A structure of the human apoptosome at 12.8 A resolution provides insights into this cell death platform. , 2005, Structure.

[133]  I. Sjaastad,et al.  Cre-loxP DNA recombination is possible with only minimal unspecific transcriptional changes and without cardiomyopathy in Tg(alphaMHC-MerCreMer) mice. , 2010, American journal of physiology. Heart and circulatory physiology.

[134]  Stefanie Dimmeler,et al.  Unchain my heart: the scientific foundations of cardiac repair. , 2005, The Journal of clinical investigation.

[135]  T. Hewett,et al.  Expression of R120G-alphaB-crystallin causes aberrant desmin and alphaB-crystallin aggregation and cardiomyopathy in mice. , 2001, Circulation research.

[136]  Peter Scarborough,et al.  EUROPEAN CARDIOVASCULAR DISEASE STATISTICS: THE EUROPEAN HEART HEALTH II (EUROHEART II) PROJECT , 2013 .

[137]  C. Thompson,et al.  Critical function of endogenous XIAP in regulating caspase activation during sympathetic neuronal apoptosis , 2003, The Journal of cell biology.

[138]  Y. Pinto,et al.  Avoidance of Transient Cardiomyopathy in Cardiomyocyte-Targeted Tamoxifen-Induced MerCreMer Gene Deletion Models , 2009, Circulation research.

[139]  J. Molkentin,et al.  ASK1 Regulates Cardiomyocyte Death but Not Hypertrophy in Transgenic Mice , 2009, Circulation research.

[140]  G. Dorn,et al.  Cardiotrophic Effects of Protein Kinase C ε Analysis by In Vivo Modulation of PKCε Translocation , 2000 .

[141]  L. Leinwand,et al.  Mice Expressing Mutant Myosin Heavy Chains Are a Model for Familial Hypertrophic Cardiomyopathy , 1996, Molecular medicine.

[142]  Dean P. Jones,et al.  The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore , 2004, Nature.

[143]  D. Burkin,et al.  Severe muscular dystrophy in mice that lack dystrophin and α7 integrin , 2006, Journal of Cell Science.

[144]  Simon C Watkins,et al.  Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[145]  D. Mann,et al.  Targeted Overexpression of Noncleavable and Secreted Forms of Tumor Necrosis Factor Provokes Disparate Cardiac Phenotypes , 2004, Circulation.

[146]  E. Olson,et al.  Dilated Cardiomyopathy and Sudden Death Resulting From Constitutive Activation of Protein Kinase A , 2001, Circulation research.

[147]  Tao Wang,et al.  Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α , 2009, Cell.

[148]  Donald M Bers,et al.  Drug Screening Using a Library of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Reveals Disease-Specific Patterns of Cardiotoxicity , 2013, Circulation.

[149]  H. Goebel,et al.  Desmin pathology in neuromuscular diseases , 1993, Virchows Archiv. B, Cell pathology including molecular pathology.

[150]  Roger R Markwald,et al.  Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β. , 2010, The Journal of clinical investigation.

[151]  J. Mate,et al.  A dysfunctional desmin mutation in a patient with severe generalized myopathy. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[152]  D. Rosenbaum,et al.  Targeted Activation of c-Jun N-terminal Kinase in Vivo Induces Restrictive Cardiomyopathy and Conduction Defects*[boxs] , 2004, Journal of Biological Chemistry.

[153]  Cristiano R. W. Guimaraes,et al.  Understanding the Impact of the P-loop Conformation on Kinase Selectivity , 2011, J. Chem. Inf. Model..

[154]  J. Robbins,et al.  Manipulation of Death Pathways in Desmin-Related Cardiomyopathy , 2010, Circulation research.

[155]  K. Mani,et al.  The Apoptosis Inhibitor ARC Undergoes Ubiquitin-Proteasomal-mediated Degradation in Response to Death Stimuli , 2007, Journal of Biological Chemistry.

[156]  M. Lohse,et al.  A Role for Caspase-1 in Heart Failure , 2007, Circulation research.

[157]  Barry Greenberg,et al.  Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): A Phase 2 Trial of Intracoronary Gene Therapy of Sarcoplasmic Reticulum Ca2+-ATPase in Patients With Advanced Heart Failure , 2011, Circulation.

[158]  Kalyani V. P. Guntur,et al.  Tumor necrosis factor alpha (TNFalpha) stimulates Map4k4 expression through TNFalpha receptor 1 signaling to c-Jun and activating transcription factor 2. , 2007, The Journal of biological chemistry.

[159]  S. Kaneko,et al.  Muscle-Specific RING Finger 1 Negatively Regulates Pathological Cardiac Hypertrophy Through Downregulation of Calcineurin A , 2014, Circulation. Heart failure.

[160]  Paul A. Overbeek,et al.  TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice , 2000, Nature Medicine.

[161]  K. Fukunaga,et al.  Inhibition of HtrA2/Omi ameliorates heart dysfunction following ischemia/reperfusion injury in rat heart in vivo. , 2007, European journal of pharmacology.

[162]  J. Beckmann,et al.  Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. , 1998, Immunity.

[163]  A. Protopopov,et al.  Role of Telomere Dysfunction in Cardiac Failure in Duchenne Muscular Dystrophy , 2013, Nature Cell Biology.

[164]  E. Murphy,et al.  Mitochondrial Dysfunction and Apoptosis Underlie the Pathogenic Process in α-B-Crystallin Desmin-Related Cardiomyopathy , 2005, Circulation.

[165]  K. Clarke,et al.  Molecular Mechanism of the E99K Mutation in Cardiac Actin (ACTC Gene) That Causes Apical Hypertrophy in Man and Mouse* , 2011, The Journal of Biological Chemistry.

[166]  J. Molkentin,et al.  Signaling effectors underlying pathologic growth and remodeling of the heart. , 2013, The Journal of clinical investigation.

[167]  A. Ashworth,et al.  Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion. , 1996, Circulation research.

[168]  J. Seidman,et al.  Genetics of congenital heart disease: the glass half empty. , 2013, Circulation research.

[169]  L. Rubin,et al.  A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS. , 2013, Cell stem cell.

[170]  Samuel Bernard,et al.  Evidence for Cardiomyocyte Renewal in Humans , 2008, Science.

[171]  S. Allender,et al.  Coronary heart disease statistics. , 2008 .

[172]  Michael D. Schneider,et al.  Telomere attrition and Chk2 activation in human heart failure , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[173]  R. Kitsis,et al.  Cell death in the pathogenesis of heart disease: mechanisms and significance. , 2010, Annual review of physiology.

[174]  P. Croisille,et al.  Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction. , 2010, Journal of the American College of Cardiology.

[175]  A. Hatzopoulos,et al.  Cardiac repair and regeneration: the Rubik’s cube of cell therapy for heart disease , 2009, Disease Models & Mechanisms.

[176]  G. Häcker,et al.  cIAPs Block Ripoptosome Formation, a RIP1/Caspase-8 Containing Intracellular Cell Death Complex Differentially Regulated by cFLIP Isoforms , 2011, Molecular cell.

[177]  V. Chapman,et al.  Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[178]  J. Miyazaki,et al.  Cardiac-specific disruption of the c-raf-1 gene induces cardiac dysfunction and apoptosis. , 2004, The Journal of clinical investigation.

[179]  R. Gottlieb,et al.  Autophagy during cardiac stress: joys and frustrations of autophagy. , 2010, Annual review of physiology.

[180]  M J Davies,et al.  Apoptotic versus autophagic cell death in heart failure. , 2001, Cardiovascular research.

[181]  Tong Zhang,et al.  The &dgr;C Isoform of CaMKII Is Activated in Cardiac Hypertrophy and Induces Dilated Cardiomyopathy and Heart Failure , 2003, Circulation research.

[182]  D. Yellon,et al.  Myocardial ischemia-reperfusion injury: a neglected therapeutic target. , 2013, The Journal of clinical investigation.

[183]  U. Smith,et al.  Impaired Preadipocyte Differentiation in Human Abdominal Obesity , 2009, Diabetes.

[184]  Jeffrey Robbins,et al.  With great power comes great responsibility: using mouse genetics to study cardiac hypertrophy and failure. , 2009, Journal of molecular and cellular cardiology.

[185]  J C Reed,et al.  Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. , 1998, Science.

[186]  Michael D. Schneider,et al.  Transgenic Expression of Bcl-2 Modulates Energy Metabolism, Prevents Cytosolic Acidification During Ischemia, and Reduces Ischemia/Reperfusion Injury , 2004, Circulation research.

[187]  Jong-Sun Kang,et al.  TGF-β-activated Kinase 1 (TAK1) and Apoptosis Signal-regulating Kinase 1 (ASK1) Interact with the Promyogenic Receptor Cdo to Promote Myogenic Differentiation via Activation of p38MAPK Pathway* , 2012, The Journal of Biological Chemistry.

[188]  H Sugita,et al.  Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. , 1991, American journal of human genetics.

[189]  M. Cho,et al.  Defective β-Adrenergic Receptor Signaling Precedes the Development of Dilated Cardiomyopathy in Transgenic Mice with Calsequestrin Overexpression* , 1999, The Journal of Biological Chemistry.

[190]  T. Hewett,et al.  Transgenic modeling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy. , 2000, Circulation research.

[191]  Q. Chen,et al.  Hydrogen peroxide dose dependent induction of cell death or hypertrophy in cardiomyocytes. , 2000, Archives of biochemistry and biophysics.

[192]  Francis G Spinale,et al.  Animal models of heart failure: a scientific statement from the American Heart Association. , 2012, Circulation research.

[193]  C A Beltrami,et al.  Apoptosis in the failing human heart. , 1997, The New England journal of medicine.

[194]  A. Koretsky,et al.  Dilated Cardiomyopathy in Transgenic Mice With Cardiac-Specific Overexpression of Tumor Necrosis Factor-α , 1997 .

[195]  K. Davies,et al.  In vivo MRI Characterization of Progressive Cardiac Dysfunction in the mdx Mouse Model of Muscular Dystrophy , 2012, PloS one.

[196]  M. Todaro,et al.  Heart-targeted overexpression of caspase3 in mice increases infarct size and depresses cardiac function , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[197]  Nico Van de Veire European Cardiovascular Disease Statistics 4 th edition 2012 : EuroHeart II , .

[198]  I. Piña,et al.  Forecasting the Impact of Heart Failure in the United States: A Policy Statement From the American Heart Association , 2013, Circulation. Heart failure.

[199]  J. Towbin,et al.  Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. , 2000, The Journal of clinical investigation.

[200]  P. Halban,et al.  Silencing Mitogen-activated Protein 4 Kinase 4 (MAP4K4) Protects Beta Cells from Tumor Necrosis Factor-α-induced Decrease of IRS-2 and Inhibition of Glucose-stimulated Insulin Secretion* , 2009, The Journal of Biological Chemistry.

[201]  Mi-Sung Kim,et al.  Requirement of protein kinase D1 for pathological cardiac remodeling , 2008, Proceedings of the National Academy of Sciences.

[202]  G. Dorn,et al.  Epsilon protein kinase C in pathological myocardial hypertrophy. Analysis by combined transgenic expression of translocation modifiers and Galphaq. , 2000, The Journal of biological chemistry.

[203]  Jason T. Su,et al.  Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy. , 1997, Circulation.

[204]  G. Dorn,et al.  Mitochondrial death protein Nix is induced in cardiac hypertrophy and triggers apoptotic cardiomyopathy , 2002, Nature Medicine.

[205]  Ke Chen,et al.  IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling , 2014, Nature Communications.

[206]  A. Halestrap,et al.  Sanglifehrin A Acts as a Potent Inhibitor of the Mitochondrial Permeability Transition and Reperfusion Injury of the Heart by Binding to Cyclophilin-D at a Different Site from Cyclosporin A* , 2002, The Journal of Biological Chemistry.

[207]  P. Ping,et al.  PKCepsilon activation induces dichotomous cardiac phenotypes and modulates PKCepsilon-RACK interactions and RACK expression. , 2001, American journal of physiology. Heart and circulatory physiology.

[208]  P. Burridge,et al.  A Review of Human Pluripotent Stem Cell-Derived Cardiomyocytes for High-Throughput Drug Discovery, Cardiotoxicity Screening, and Publication Standards , 2013, Journal of Cardiovascular Translational Research.

[209]  Xiaodong Wang,et al.  TNF-α Induces Two Distinct Caspase-8 Activation Pathways , 2008, Cell.

[210]  Y. Lin,et al.  Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. , 1999, Genes & development.

[211]  Q. Liang,et al.  Reengineering Inducible Cardiac-Specific Transgenesis With an Attenuated Myosin Heavy Chain Promoter , 2003, Circulation research.

[212]  Michael D. Schneider,et al.  The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function , 2006, Nature Immunology.

[213]  R. Gottlieb,et al.  Functional and clinical repercussions of myocyte apoptosis in the multifaceted damage by ischemia/reperfusion injury: old and new concepts after 10 years of contributions , 2004, Cell Death and Differentiation.

[214]  Liza S. M. Wong,et al.  Telomere biology in cardiovascular disease: the TERC-/- mouse as a model for heart failure and ageing. , 2008, Cardiovascular research.

[215]  Brian Seed,et al.  Fas triggers an alternative, caspase-8–independent cell death pathway using the kinase RIP as effector molecule , 2000, Nature Immunology.

[216]  J. Seidman,et al.  Electrophysiological abnormalities and arrhythmias in alpha MHC mutant familial hypertrophic cardiomyopathy mice. , 1997, The Journal of clinical investigation.

[217]  T. Hewett,et al.  Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. , 2007, The Journal of clinical investigation.

[218]  D. Burkin,et al.  Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin. , 2006, Journal of cell science.

[219]  G. Dorn,et al.  Interactions Between Phospholamban and &bgr;-Adrenergic Drive May Lead to Cardiomyopathy and Early Mortality , 2001, Circulation.

[220]  F. Muntoni,et al.  Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. , 1993, The New England journal of medicine.

[221]  M. Prevost,et al.  Bcl-2 and Bax modulate adenine nucleotide translocase activity. , 2003, Cancer research.

[222]  D. Mancini,et al.  Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial. , 2009, Journal of cardiac failure.

[223]  W. Craigen,et al.  Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death , 2007, Nature Cell Biology.

[224]  Masashi Narita,et al.  Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC , 1999, Nature.

[225]  S. Korsmeyer,et al.  VDAC2 Inhibits BAK Activation and Mitochondrial Apoptosis , 2003, Science.

[226]  Christoph Preuss,et al.  Genetics of heart failure in congenital heart disease. , 2013, The Canadian journal of cardiology.

[227]  Michael D. Schneider,et al.  Cardiac muscle regeneration: lessons from development. , 2011, Genes & development.

[228]  M. Schulze,et al.  Association of Common Genetic Variants in the MAP4K4 Locus with Prediabetic Traits in Humans , 2012, PloS one.

[229]  J. McMurray,et al.  Targeted Anticytokine Therapy in Patients With Chronic Heart Failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL) , 2004, Circulation.

[230]  M. Mocanu,et al.  The Cardioprotective Effect of Necrostatin Requires the Cyclophilin-D Component of the Mitochondrial Permeability Transition Pore , 2007, Cardiovascular Drugs and Therapy.

[231]  Jonathan Seidman,et al.  Genetic causes of human heart failure. , 2005, The Journal of clinical investigation.

[232]  D. Duan,et al.  Partial restoration of cardiac function with ΔPDZ nNOS in aged mdx model of Duchenne cardiomyopathy. , 2014, Human molecular genetics.

[233]  T. Hewett,et al.  Expression of R120G–αB-Crystallin Causes Aberrant Desmin and αB-Crystallin Aggregation and Cardiomyopathy in Mice , 2001 .

[234]  K. Moore,et al.  X chromosome-linked muscular dystrophy (mdx) in the mouse. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[235]  H. Schulman,et al.  Disease mechanisms and emerging therapies: protein kinases and their inhibitors in myocardial disease , 2006, Nature Clinical Practice Cardiovascular Medicine.

[236]  Douglas L. Mann,et al.  Heart Failure: a Companion to Braunwald's Heart Disease , 2014 .

[237]  James O. Mudd,et al.  An abnormal Ca2+ response in mutant sarcomere protein–mediated familial hypertrophic cardiomyopathy , 2000 .

[238]  M. Lotze,et al.  The Beclin 1 network regulates autophagy and apoptosis , 2011, Cell Death and Differentiation.

[239]  M. Gautel,et al.  Protein Kinase D Is a Novel Mediator of Cardiac Troponin I Phosphorylation and Regulates Myofilament Function , 2004, Circulation research.

[240]  D. Goeddel,et al.  Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. , 2000, Immunity.

[241]  L. Masterson,et al.  Structural and Dynamic Basis of Phospholamban and Sarcolipin Inhibition of Ca2+-ATPase† , 2008 .

[242]  D. Mann,et al.  Cardiac myocyte apoptosis provokes adverse cardiac remodeling in transgenic mice with targeted TNF overexpression. , 2004, American journal of physiology. Heart and circulatory physiology.

[243]  E. Rozengurt,et al.  Expression and activity of protein kinase D/protein kinase C mu in myocardium: evidence for alpha1-adrenergic receptor- and protein kinase C-mediated regulation. , 2000, Journal of molecular and cellular cardiology.

[244]  S. Sengupta,et al.  Role of α-crystallin B as a regulatory switch in modulating cardiomyocyte apoptosis by mitochondria or endoplasmic reticulum during cardiac hypertrophy and myocardial infarction , 2013, Cell Death and Disease.

[245]  M. Xie,et al.  Phosphorylation of Thr-178 and Thr-184 in the TAK1 T-loop Is Required for Interleukin (IL)-1-mediated Optimal NFκB and AP-1 Activation as Well as IL-6 Gene Expression* , 2008, Journal of Biological Chemistry.

[246]  J. Towbin,et al.  X‐Linked Dilated Cardiomyopathy Molecular Genetic Evidence of Linkage to the Duchenne Muscular Dystrophy (Dystrophin) Gene at the Xp21 Locus , 1993, Circulation.

[247]  L. Leinwand,et al.  Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. , 2001, The Journal of clinical investigation.

[248]  J. Schaper,et al.  Progression From Compensated Hypertrophy to Failure in the Pressure-Overloaded Human Heart: Structural Deterioration and Compensatory Mechanisms , 2003, Circulation.

[249]  L. Mestroni,et al.  Dystrophin gene abnormalities in two patients with idiopathic dilated cardiomyopathy , 1997, Heart.

[250]  S. Cook,et al.  Are transgenic mice the 'alkahest' to understanding myocardial hypertrophy and failure? , 2009, Journal of molecular and cellular cardiology.

[251]  G. Dorn,et al.  Cardiotrophic effects of protein kinase C epsilon: analysis by in vivo modulation of PKCepsilon translocation. , 2000, Circulation research.

[252]  M. Morad,et al.  Regulation of Ca2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin. , 1998, The Journal of clinical investigation.

[253]  B. Levine,et al.  The autophagy effector Beclin 1: a novel BH3-only protein , 2008, Oncogene.

[254]  K. Kariya,et al.  Mitogen-activated Protein Kinase Kinase Kinase Kinase 4 as a Putative Effector of Rap2 to Activate the c-Jun N-terminal Kinase* , 2004, Journal of Biological Chemistry.

[255]  G. Dorn,et al.  Dual autonomous mitochondrial cell death pathways are activated by Nix/BNip3L and induce cardiomyopathy , 2010, Proceedings of the National Academy of Sciences.

[256]  E. Kranias,et al.  From mouse to man: understanding heart failure through genetically altered mouse models. , 2002, Journal of cardiac failure.

[257]  J. Molkentin,et al.  Developing small molecules to inhibit kinases unkind to the heart: p38 MAPK as a case in point. , 2010, Drug discovery today. Disease mechanisms.

[258]  G. King,et al.  Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[259]  L. Tesson,et al.  Generation of TALEN-Mediated GRdim Knock-In Rats by Homologous Recombination , 2014, PloS one.

[260]  James O. Mudd,et al.  An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy. , 2000, The Journal of clinical investigation.

[261]  L. Leinwand,et al.  Progression from hypertrophic to dilated cardiomyopathy in mice that express a mutant myosin transgene. , 2001, American journal of physiology. Heart and circulatory physiology.

[262]  N. Maeda,et al.  The role of natriuretic peptides in cardioprotection. , 2006, Cardiovascular research.

[263]  J. Robbins,et al.  Cardiomyocyte Expression of a Polyglutamine Preamyloid Oligomer Causes Heart Failure , 2008, Circulation.

[264]  J. Richardson,et al.  Cardiac autophagy is a maladaptive response to hemodynamic stress. , 2007, The Journal of clinical investigation.

[265]  M. Czech,et al.  Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation , 2009, Nature.

[266]  V. Chapman,et al.  The Frequency of Revertants in mdx Mouse Genetic Models for Duchenne Muscular Dystrophy , 1992, Pediatric Research.

[267]  Michael D. Schneider,et al.  TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways. , 2007, The Journal of clinical investigation.

[268]  R. Lefkowitz,et al.  Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[269]  C. Barbas,et al.  ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. , 2013, Trends in biotechnology.

[270]  J. Slightom,et al.  Differential expression of dystrophin isoforms in strains of mdx mice with different mutations. , 1996, Human molecular genetics.

[271]  Rick B. Vega,et al.  Protein Kinases C and D Mediate Agonist-Dependent Cardiac Hypertrophy through Nuclear Export of Histone Deacetylase 5 , 2004, Molecular and Cellular Biology.

[272]  T. Kita,et al.  Activation of TGF-β1-TAK1-p38 MAPK pathway in spared cardiomyocytes is involved in left ventricular remodeling after myocardial infarction in rats , 2006 .

[273]  P. Anversa,et al.  A matter of life and death: cardiac myocyte apoptosis and regeneration. , 2003, The Journal of clinical investigation.

[274]  Guey-Shin Wang,et al.  PKC inhibition ameliorates the cardiac phenotype in a mouse model of myotonic dystrophy type 1. , 2009, The Journal of clinical investigation.

[275]  Jiahuai Han,et al.  Cardiac Hypertrophy Induced by Mitogen-activated Protein Kinase Kinase 7, a Specific Activator for c-Jun NH2-terminal Kinase in Ventricular Muscle Cells* , 1998, The Journal of Biological Chemistry.

[276]  H. Sweeney,et al.  Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy , 2008, Nature Medicine.

[277]  A. Feldman,et al.  Phospholamban gene ablation improves calcium transients but not cardiac function in a heart failure model. , 2004, Cardiovascular research.

[278]  S. Akira,et al.  Mitochondrial DNA That Escapes from Autophagy Causes Inflammation and Heart Failure , 2012, Nature.

[279]  M. Rudnicki,et al.  Severe cardiomyopathy in mice lacking dystrophin and MyoD. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[280]  M. Peter The flip side of FLIP. , 2004, The Biochemical journal.

[281]  P. Doevendans,et al.  Targeting cell death in the reperfused heart: pharmacological approaches for cardioprotection. , 2013, International journal of cardiology.

[282]  Y. Capetanaki,et al.  Disruption of muscle architecture and myocardial degeneration in mice lacking desmin , 1996, The Journal of cell biology.

[283]  G. Dorn,et al.  Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 restrains postinfarction remodeling in mice. , 2007, The Journal of clinical investigation.

[284]  B. Rothermel,et al.  Autophagy in load-induced heart disease. , 2008, Circulation research.

[285]  S. Delp,et al.  Short Telomeres and Stem Cell Exhaustion Model Duchenne Muscular Dystrophy in mdx/mTR Mice , 2010, Cell.

[286]  J. Stamler,et al.  Convergence of G Protein–Coupled Receptor and S-Nitrosylation Signaling Determines the Outcome to Cardiac Ischemic Injury , 2013, Science Signaling.

[287]  Michael E. Hall,et al.  Systolic dysfunction in cardiac-specific ligand-inducible MerCreMer transgenic mice. , 2011, American journal of physiology. Heart and circulatory physiology.

[288]  E. Levin,et al.  Estrogen Prevents Cardiomyocyte Apoptosis through Inhibition of Reactive Oxygen Species and Differential Regulation of p38 Kinase Isoforms* , 2006, Journal of Biological Chemistry.

[289]  Alan V. Smrcka,et al.  Differential Targeting of Gßγ-Subunit Signaling with Small Molecules , 2006, Science.

[290]  P. Ping,et al.  Enhanced PKCβII translocation and PKCβII-RACK1 interactions in PKCε-induced heart failure: a role for RACK1 , 2001 .

[291]  S. Knapp,et al.  Mechanism and consequence of the autoactivation p38α Mitogen-activated Protein Kinase promoted by TAB1 , 2013, Nature Structural &Molecular Biology.

[292]  PJ Willems,et al.  Genetic factors in non‐syndromic congenital heart malformations , 2010, Clinical genetics.

[293]  Nico Tjandra,et al.  Structure of Bax Coregulation of Dimer Formation and Intracellular Localization , 2000, Cell.

[294]  Gabriel Pineda,et al.  Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. , 2006, Molecular cell.

[295]  Xiaodong Wang,et al.  Smac, a Mitochondrial Protein that Promotes Cytochrome c–Dependent Caspase Activation by Eliminating IAP Inhibition , 2000, Cell.

[296]  T. Strandberg,et al.  The roles of senescence and telomere shortening in cardiovascular disease , 2013, Nature Reviews Cardiology.

[297]  J. Finsterer,et al.  Treatment of dystrophin cardiomyopathies , 2014, Nature Reviews Cardiology.

[298]  S. Burchill,et al.  p38(MAPK): stress responses from molecular mechanisms to therapeutics. , 2009, Trends in molecular medicine.

[299]  T. Tan,et al.  A Novel Human STE20-related Protein Kinase, HGK, That Specifically Activates the c-Jun N-terminal Kinase Signaling Pathway* , 1999, The Journal of Biological Chemistry.

[300]  H. Rakowski,et al.  A CMR study of left atrial mechanics in hypertrophic cardiomyopathy: left atrial function predicts paroxysmal atrial fibrillation , 2013 .

[301]  G. Dorn,et al.  Additive Protection of the Ischemic Heart Ex Vivo by Combined Treatment With &dgr;-Protein Kinase C Inhibitor and &egr;-Protein Kinase C Activator , 2003 .

[302]  J. Ornato,et al.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .

[303]  G. Dorn,et al.  Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level. , 2000, Circulation.

[304]  W. Linke,et al.  Telethonin Deficiency Is Associated With Maladaptation to Biomechanical Stress in the Mammalian Heart , 2011, Circulation research.

[305]  J. Butler,et al.  Heart Failure 2012 , 2012, Cardiology research and practice.

[306]  L. Mestroni,et al.  A point mutation in the 5' splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy. , 1996, Human molecular genetics.

[307]  Shih-Ann Chen,et al.  Histone deacetylase inhibition improved cardiac functions with direct antifibrotic activity in heart failure. , 2013, International journal of cardiology.

[308]  M. Marber,et al.  New therapeutic targets in cardiology: p38 alpha mitogen-activated protein kinase for ischemic heart disease. , 2012, Circulation.

[309]  K. Chien,et al.  The MEKK-JNK Pathway Is Stimulated by α1-Adrenergic Receptor and Ras Activation and Is Associated with in Vitroand in Vivo Cardiac Hypertrophy* , 1997, The Journal of Biological Chemistry.

[310]  M. Sano,et al.  Cyclin-Dependent Kinase-9 An RNAPII Kinase at the Nexus of Cardiac Growth and Death Cascades , 2004 .

[311]  Pierre Croisille,et al.  Effect of cyclosporine on reperfusion injury in acute myocardial infarction. , 2008, The New England journal of medicine.

[312]  M. Lohse,et al.  Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[313]  Henrik Westerberg,et al.  A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains , 2013, Genome Biology.

[314]  W. Craigen,et al.  Activation of cardiac Cdk9 represses PGC‐1 and confers a predisposition to heart failure , 2004, The EMBO journal.

[315]  Michael D. Schneider,et al.  Activation of Rho-associated coiled-coil protein kinase 1 (ROCK-1) by caspase-3 cleavage plays an essential role in cardiac myocyte apoptosis , 2006, Proceedings of the National Academy of Sciences.

[316]  J. Metzger Cardiac muscle regeneration , 1982 .

[317]  A. Demetris,et al.  Cardiac-specific overexpression of tumor necrosis factor-alpha causes lethal myocarditis in transgenic mice. , 1997, Journal of cardiac failure.

[318]  Padmini Sarathchandra,et al.  Cardiac fibrosis in mice expressing an inducible myocardial-specific Cre driver , 2013, Disease Models & Mechanisms.

[319]  J. Molkentin,et al.  TRPC Channels As Effectors of Cardiac Hypertrophy , 2011, Circulation research.

[320]  G. Dorn,et al.  Transgenic Galphaq overexpression induces cardiac contractile failure in mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[321]  Ciro Indolfi,et al.  Adult c-kitpos Cardiac Stem Cells Are Necessary and Sufficient for Functional Cardiac Regeneration and Repair , 2013, Cell.

[322]  Michael D. Schneider,et al.  Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy , 2005, Cell.

[323]  Dianqing Wu,et al.  Differential targeting of Gbetagamma-subunit signaling with small molecules. , 2006, Science.

[324]  Dian J. Cao,et al.  Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy , 2011, Proceedings of the National Academy of Sciences.

[325]  Thomas M. Keane,et al.  Resource Genome Sequencing Reveals Loci under Artificial Selection that Underlie Disease Phenotypes in the Laboratory Rat , 2013 .

[326]  G. Dorn,et al.  Rescue of Contractile Parameters and Myocyte Hypertrophy in Calsequestrin Overexpressing Myocardium by Phospholamban Ablation* , 2001, The Journal of Biological Chemistry.

[327]  G. Taffet,et al.  Bcl-2 overexpression corrects mitochondrial defects and ameliorates inherited desmin null cardiomyopathy. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[328]  R. Kitsis,et al.  A mechanistic role for cardiac myocyte apoptosis in heart failure. , 2003, The Journal of clinical investigation.

[329]  G. Boivin,et al.  A familial hypertrophic cardiomyopathy alpha-tropomyosin mutation causes severe cardiac hypertrophy and death in mice. , 2001, Journal of molecular and cellular cardiology.

[330]  K. Das,et al.  Protein kinase C, an elusive therapeutic target? , 2012, Nature Reviews Drug Discovery.

[331]  B. Gersh,et al.  Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality. , 1995, Circulation.

[332]  Lei Shi,et al.  Structural and Dynamic Basis of Phospholamban and Sarcolipin Inhibition of , 2008 .

[333]  P. Powers,et al.  Cardiac troponin I gene knockout: a mouse model of myocardial troponin I deficiency. , 1999, Circulation research.

[334]  A. Ibrahim,et al.  Acute myocardial infarction. , 2014, Critical care clinics.

[335]  D. Goeddel,et al.  FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. , 1998, Science.

[336]  T. Hewett,et al.  PKC-α regulates cardiac contractility and propensity toward heart failure , 2004, Nature Medicine.

[337]  R. Kitsis,et al.  Ubiquitination and Degradation of the Anti-apoptotic Protein ARC by MDM2* , 2007, Journal of Biological Chemistry.

[338]  S. Silver,et al.  Heart Failure , 1937, The New England journal of medicine.

[339]  E. Niggli,et al.  Cardiac phenotype of Duchenne Muscular Dystrophy: insights from cellular studies. , 2013, Journal of molecular and cellular cardiology.

[340]  F. Muntoni,et al.  The absence of dystrophin brain isoform expression in healthy human heart ventricles explains the pathogenesis of 5' X-linked dilated cardiomyopathy , 2012, BMC Medical Genetics.

[341]  Yibin Wang,et al.  Role of an alternatively spliced form of alphaII-spectrin in localization of connexin 43 in cardiomyocytes and regulation by stress-activated protein kinase. , 2007, Journal of molecular and cellular cardiology.

[342]  Michael D. Schneider,et al.  A pivotal role for endogenous TGF-β-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway , 2006, Proceedings of the National Academy of Sciences.

[343]  Kalyani V. P. Guntur,et al.  Tumor Necrosis Factor α (TNFα) Stimulates Map4k4 Expression through TNFα Receptor 1 Signaling to c-Jun and Activating Transcription Factor 2* , 2007, Journal of Biological Chemistry.

[344]  G. Dorn,et al.  Mouse Model of Desmin-Related Cardiomyopathy , 2001, Circulation.

[345]  J. Gummert,et al.  Inhibition of Elevated Ca2+/Calmodulin-Dependent Protein Kinase II Improves Contractility in Human Failing Myocardium , 2010, Circulation research.

[346]  C. Baines The mitochondrial permeability transition pore as a target of cardioprotective signaling. , 2007, American journal of physiology. Heart and circulatory physiology.

[347]  Xiaoqing Tang,et al.  An RNA interference-based screen identifies MAP4K4/NIK as a negative regulator of PPARγ, adipogenesis, and insulin-responsive hexose transport , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[348]  V. Kytö,et al.  Apoptotic cardiomyocyte death in fatal myocarditis. , 2004, The American journal of cardiology.